APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidiuretic Hormone (ADH)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antidiuretic Hormone (ADH) Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchAntidiuretic Hormone (ADH) Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiuretic Hormone (ADH) Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Antidiuretic Hormone (ADH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiuretic Hormone (ADH) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiuretic Hormone (ADH) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Antidiuretic Hormone (ADH) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Antidiuretic Hormone (ADH) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antidiuretic Hormone (ADH) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antidiuretic Hormone (ADH) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antidiuretic Hormone (ADH) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Antidiuretic Hormone (ADH) include Shanghai Soho-Yiming Pharmaceuticals, Novartis, Pfizer, Ferring Pharmaceuticals, Fresenius Kabi, Par Pharmaceutical and Astellas Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Antidiuretic Hormone (ADH), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antidiuretic Hormone (ADH), also provides the revenue of main regions and countries. Of the upcoming market potential for Antidiuretic Hormone (ADH), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antidiuretic Hormone (ADH) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antidiuretic Hormone (ADH) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antidiuretic Hormone (ADH) revenue, projected growth trends, production technology, application and end-user industry.

Antidiuretic Hormone (ADH) Segment by Company

Shanghai Soho-Yiming Pharmaceuticals

Novartis

Pfizer

Ferring Pharmaceuticals

Fresenius Kabi

Par Pharmaceutical

Astellas Pharma

Antidiuretic Hormone (ADH) Segment by Type

Subcutaneous Injection

Intravenous Injection

Intramuscular Injection

Antidiuretic Hormone (ADH) Segment by Application

Vasodilatory Shock

Gastrointestinal Bleeding

Ventricular Tachycardia & Fibrillation

Anti-Diuretic Hormone Deficiency

Antidiuretic Hormone (ADH) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiuretic Hormone (ADH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiuretic Hormone (ADH) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiuretic Hormone (ADH).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antidiuretic Hormone (ADH) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antidiuretic Hormone (ADH) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antidiuretic Hormone (ADH) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antidiuretic Hormone (ADH) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Subcutaneous Injection Major Player Table 3. Intravenous Injection Major Player Table 4. Intramuscular Injection Major Player Table 5. Global Antidiuretic Hormone (ADH) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Vasodilatory Shock Major Player Table 7. Gastrointestinal Bleeding Major Player Table 8. Ventricular Tachycardia & Fibrillation Major Player Table 9. Anti-Diuretic Hormone Deficiency Major Player Table 10. Antidiuretic Hormone (ADH) Industry Trends Table 11. Antidiuretic Hormone (ADH) Industry Drivers Table 12. Antidiuretic Hormone (ADH) Industry Opportunities and Challenges Table 13. Antidiuretic Hormone (ADH) Industry Restraints Table 14. Global Antidiuretic Hormone (ADH) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Antidiuretic Hormone (ADH) Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Antidiuretic Hormone (ADH) Market Share by Region (2021-2026) Table 17. Global Antidiuretic Hormone (ADH) Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Antidiuretic Hormone (ADH) Market Share by Region (2027-2032) Table 19. Global Antidiuretic Hormone (ADH) Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Antidiuretic Hormone (ADH) Revenue Market Share by Players (2021-2026) Table 21. Global Antidiuretic Hormone (ADH) Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Antidiuretic Hormone (ADH) Key Players Headquarters & Area Served Table 23. Global Antidiuretic Hormone (ADH) Players, Product Type & Application Table 24. Global Antidiuretic Hormone (ADH) Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Antidiuretic Hormone (ADH) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Antidiuretic Hormone (ADH) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Antidiuretic Hormone (ADH) Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Antidiuretic Hormone (ADH) Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Antidiuretic Hormone (ADH) Revenue Market Share by Type (2021-2026) Table 31. Global Antidiuretic Hormone (ADH) Revenue Market Share by Type (2027-2032) Table 32. Global Antidiuretic Hormone (ADH) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antidiuretic Hormone (ADH) Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Antidiuretic Hormone (ADH) Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Antidiuretic Hormone (ADH) Revenue Market Share by Application (2021-2026) Table 36. Global Antidiuretic Hormone (ADH) Revenue Market Share by Application (2027-2032) Table 37. Shanghai Soho-Yiming Pharmaceuticals Company Information Table 38. Shanghai Soho-Yiming Pharmaceuticals Business Overview Table 39. Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio Table 41. Shanghai Soho-Yiming Pharmaceuticals Recent Development Table 42. Novartis Company Information Table 43. Novartis Business Overview Table 44. Novartis Antidiuretic Hormone (ADH) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Novartis Antidiuretic Hormone (ADH) Product Portfolio Table 46. Novartis Recent Development Table 47. Pfizer Company Information Table 48. Pfizer Business Overview Table 49. Pfizer Antidiuretic Hormone (ADH) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Pfizer Antidiuretic Hormone (ADH) Product Portfolio Table 51. Pfizer Recent Development Table 52. Ferring Pharmaceuticals Company Information Table 53. Ferring Pharmaceuticals Business Overview Table 54. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio Table 56. Ferring Pharmaceuticals Recent Development Table 57. Fresenius Kabi Company Information Table 58. Fresenius Kabi Business Overview Table 59. Fresenius Kabi Antidiuretic Hormone (ADH) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Fresenius Kabi Antidiuretic Hormone (ADH) Product Portfolio Table 61. Fresenius Kabi Recent Development Table 62. Par Pharmaceutical Company Information Table 63. Par Pharmaceutical Business Overview Table 64. Par Pharmaceutical Antidiuretic Hormone (ADH) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Par Pharmaceutical Antidiuretic Hormone (ADH) Product Portfolio Table 66. Par Pharmaceutical Recent Development Table 67. Astellas Pharma Company Information Table 68. Astellas Pharma Business Overview Table 69. Astellas Pharma Antidiuretic Hormone (ADH) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Astellas Pharma Antidiuretic Hormone (ADH) Product Portfolio Table 71. Astellas Pharma Recent Development Table 72. North America Antidiuretic Hormone (ADH) Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Antidiuretic Hormone (ADH) Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Antidiuretic Hormone (ADH) Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Antidiuretic Hormone (ADH) Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Antidiuretic Hormone (ADH) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Antidiuretic Hormone (ADH) Revenue by Country (2021-2026) & (US$ Million) Table 78. North America Antidiuretic Hormone (ADH) Revenue by Country (US$ Million) & (2027-2032) Table 79. Europe Antidiuretic Hormone (ADH) Revenue by Type (2021-2026) & (US$ Million) Table 80. Europe Antidiuretic Hormone (ADH) Revenue by Type (2027-2032) & (US$ Million) Table 81. Europe Antidiuretic Hormone (ADH) Revenue by Application (2021-2026) & (US$ Million) Table 82. Europe Antidiuretic Hormone (ADH) Revenue by Application (2027-2032) & (US$ Million) Table 83. Europe Antidiuretic Hormone (ADH) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Europe Antidiuretic Hormone (ADH) Revenue by Country (2021-2026) & (US$ Million) Table 85. Europe Antidiuretic Hormone (ADH) Revenue by Country (US$ Million) & (2027-2032) Table 86. China Antidiuretic Hormone (ADH) Revenue by Type (2021-2026) & (US$ Million) Table 87. China Antidiuretic Hormone (ADH) Revenue by Type (2027-2032) & (US$ Million) Table 88. China Antidiuretic Hormone (ADH) Revenue by Application (2021-2026) & (US$ Million) Table 89. China Antidiuretic Hormone (ADH) Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Antidiuretic Hormone (ADH) Revenue by Type (2021-2026) & (US$ Million) Table 91. Asia Antidiuretic Hormone (ADH) Revenue by Type (2027-2032) & (US$ Million) Table 92. Asia Antidiuretic Hormone (ADH) Revenue by Application (2021-2026) & (US$ Million) Table 93. Asia Antidiuretic Hormone (ADH) Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Antidiuretic Hormone (ADH) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Asia Antidiuretic Hormone (ADH) Revenue by Region (US$ Million) & (2021-2026) Table 96. Asia Antidiuretic Hormone (ADH) Revenue by Region (US$ Million) & (2027-2032) Table 97. SAMEA Antidiuretic Hormone (ADH) Revenue by Type (2021-2026) & (US$ Million) Table 98. SAMEA Antidiuretic Hormone (ADH) Revenue by Type (2027-2032) & (US$ Million) Table 99. SAMEA Antidiuretic Hormone (ADH) Revenue by Application (2021-2026) & (US$ Million) Table 100. SAMEA Antidiuretic Hormone (ADH) Revenue by Application (2027-2032) & (US$ Million) Table 101. SAMEA Antidiuretic Hormone (ADH) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. SAMEA Antidiuretic Hormone (ADH) Revenue by Country (2021-2026) & (US$ Million) Table 103. SAMEA Antidiuretic Hormone (ADH) Revenue by Country (US$ Million) & (2027-2032) Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Antidiuretic Hormone (ADH) Image Figure 2. Global Antidiuretic Hormone (ADH) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiuretic Hormone (ADH) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Subcutaneous Injection Image Figure 5. Intravenous Injection Image Figure 6. Intramuscular Injection Image Figure 7. Global Antidiuretic Hormone (ADH) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Antidiuretic Hormone (ADH) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Vasodilatory Shock Image Figure 10. Gastrointestinal Bleeding Image Figure 11. Ventricular Tachycardia & Fibrillation Image Figure 12. Anti-Diuretic Hormone Deficiency Image Figure 13. Global Antidiuretic Hormone (ADH) Market Size (US$ Million) & (2021-2032) Figure 14. Global Antidiuretic Hormone (ADH) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Antidiuretic Hormone (ADH) Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Antidiuretic Hormone (ADH) Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Antidiuretic Hormone (ADH) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Antidiuretic Hormone (ADH) Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Antidiuretic Hormone (ADH) Revenue Market Share by Type (2021-2032) Figure 21. Global Antidiuretic Hormone (ADH) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Antidiuretic Hormone (ADH) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Antidiuretic Hormone (ADH) Revenue Market Share by Application (2021-2032) Figure 24. North America Antidiuretic Hormone (ADH) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032) Figure 26. North America Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032) Figure 27. North America Antidiuretic Hormone (ADH) Revenue Share by Country (2021-2032) Figure 28. United States Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Antidiuretic Hormone (ADH) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032) Figure 33. Europe Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032) Figure 34. Europe Antidiuretic Hormone (ADH) Revenue Share by Country (2021-2032) Figure 35. Germany Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Antidiuretic Hormone (ADH) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032) Figure 45. China Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032) Figure 46. Asia Antidiuretic Hormone (ADH) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032) Figure 48. Asia Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032) Figure 49. Asia Antidiuretic Hormone (ADH) Revenue Share by Region (2021-2032) Figure 50. Japan Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Antidiuretic Hormone (ADH) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032) Figure 58. SAMEA Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032) Figure 59. SAMEA Antidiuretic Hormone (ADH) Revenue Share by Country (2021-2032) Figure 60. Brazil Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Antidiuretic Hormone (ADH) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Injection
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Vasodilatory Shock
  • Gastrointestinal Bleeding
  • Ventricular Tachycardia & Fibrillation
  • Anti-Diuretic Hormone Deficiency
Companies covered
  • Shanghai Soho-Yiming Pharmaceuticals
  • Novartis
  • Pfizer
  • Ferring Pharmaceuticals
  • Fresenius Kabi
  • Par Pharmaceutical
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antidiuretic Hormone (ADH) Market by Type
  3. 1.2.1 Global Antidiuretic Hormone (ADH) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Subcutaneous Injection
  5. 1.2.3 Intravenous Injection
  6. 1.2.4 Intramuscular Injection
  7. 1.3 Antidiuretic Hormone (ADH) Market by Application
  8. 1.3.1 Global Antidiuretic Hormone (ADH) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Vasodilatory Shock
  10. 1.3.3 Gastrointestinal Bleeding
  11. 1.3.4 Ventricular Tachycardia & Fibrillation
  12. 1.3.5 Anti-Diuretic Hormone Deficiency
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Antidiuretic Hormone (ADH) Market Dynamics
  1. 2.1 Antidiuretic Hormone (ADH) Industry Trends
  2. 2.2 Antidiuretic Hormone (ADH) Industry Drivers
  3. 2.3 Antidiuretic Hormone (ADH) Industry Opportunities and Challenges
  4. 2.4 Antidiuretic Hormone (ADH) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antidiuretic Hormone (ADH) Market Perspective (2021-2032)
  2. 3.2 Global Antidiuretic Hormone (ADH) Growth Trends by Region
  3. 3.2.1 Global Antidiuretic Hormone (ADH) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antidiuretic Hormone (ADH) Market Size by Region (2021-2026)
  5. 3.2.3 Global Antidiuretic Hormone (ADH) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antidiuretic Hormone (ADH) Revenue by Players
  2. 4.1.1 Global Antidiuretic Hormone (ADH) Revenue by Players (2021-2026)
  3. 4.1.2 Global Antidiuretic Hormone (ADH) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antidiuretic Hormone (ADH) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antidiuretic Hormone (ADH) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antidiuretic Hormone (ADH) Key Players Headquarters & Area Served
  7. 4.4 Global Antidiuretic Hormone (ADH) Players, Product Type & Application
  8. 4.5 Global Antidiuretic Hormone (ADH) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antidiuretic Hormone (ADH) Market CR5 and HHI
  11. 4.6.3 2025 Antidiuretic Hormone (ADH) Tier 1, Tier 2, and Tier 3
5 Antidiuretic Hormone (ADH) Market Size by Type
  1. 5.1 Global Antidiuretic Hormone (ADH) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antidiuretic Hormone (ADH) Revenue by Type (2021-2032)
  3. 5.3 Global Antidiuretic Hormone (ADH) Revenue Market Share by Type (2021-2032)
6 Antidiuretic Hormone (ADH) Market Size by Application
  1. 6.1 Global Antidiuretic Hormone (ADH) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antidiuretic Hormone (ADH) Revenue by Application (2021-2032)
  3. 6.3 Global Antidiuretic Hormone (ADH) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Shanghai Soho-Yiming Pharmaceuticals
  2. 7.1.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
  3. 7.1.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  4. 7.1.3 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
  6. 7.1.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Antidiuretic Hormone (ADH) Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Antidiuretic Hormone (ADH) Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Ferring Pharmaceuticals
  20. 7.4.1 Ferring Pharmaceuticals Company Information
  21. 7.4.2 Ferring Pharmaceuticals Business Overview
  22. 7.4.3 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
  24. 7.4.5 Ferring Pharmaceuticals Recent Developments
  25. 7.5 Fresenius Kabi
  26. 7.5.1 Fresenius Kabi Company Information
  27. 7.5.2 Fresenius Kabi Business Overview
  28. 7.5.3 Fresenius Kabi Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Fresenius Kabi Antidiuretic Hormone (ADH) Product Portfolio
  30. 7.5.5 Fresenius Kabi Recent Developments
  31. 7.6 Par Pharmaceutical
  32. 7.6.1 Par Pharmaceutical Company Information
  33. 7.6.2 Par Pharmaceutical Business Overview
  34. 7.6.3 Par Pharmaceutical Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Par Pharmaceutical Antidiuretic Hormone (ADH) Product Portfolio
  36. 7.6.5 Par Pharmaceutical Recent Developments
  37. 7.7 Astellas Pharma
  38. 7.7.1 Astellas Pharma Company Information
  39. 7.7.2 Astellas Pharma Business Overview
  40. 7.7.3 Astellas Pharma Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Astellas Pharma Antidiuretic Hormone (ADH) Product Portfolio
  42. 7.7.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America Antidiuretic Hormone (ADH) Revenue (2021-2032)
  2. 8.2 North America Antidiuretic Hormone (ADH) Revenue by Type (2021-2032)
  3. 8.2.1 North America Antidiuretic Hormone (ADH) Revenue by Type (2021-2026)
  4. 8.2.2 North America Antidiuretic Hormone (ADH) Revenue by Type (2027-2032)
  5. 8.3 North America Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032)
  6. 8.4 North America Antidiuretic Hormone (ADH) Revenue by Application (2021-2032)
  7. 8.4.1 North America Antidiuretic Hormone (ADH) Revenue by Application (2021-2026)
  8. 8.4.2 North America Antidiuretic Hormone (ADH) Revenue by Application (2027-2032)
  9. 8.5 North America Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032)
  10. 8.6 North America Antidiuretic Hormone (ADH) Revenue by Country
  11. 8.6.1 North America Antidiuretic Hormone (ADH) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antidiuretic Hormone (ADH) Revenue by Country (2021-2026)
  13. 8.6.3 North America Antidiuretic Hormone (ADH) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Antidiuretic Hormone (ADH) Revenue (2021-2032)
  2. 9.2 Europe Antidiuretic Hormone (ADH) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antidiuretic Hormone (ADH) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antidiuretic Hormone (ADH) Revenue by Type (2027-2032)
  5. 9.3 Europe Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antidiuretic Hormone (ADH) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antidiuretic Hormone (ADH) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antidiuretic Hormone (ADH) Revenue by Application (2027-2032)
  9. 9.5 Europe Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antidiuretic Hormone (ADH) Revenue by Country
  11. 9.6.1 Europe Antidiuretic Hormone (ADH) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antidiuretic Hormone (ADH) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antidiuretic Hormone (ADH) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Antidiuretic Hormone (ADH) Revenue (2021-2032)
  2. 10.2 China Antidiuretic Hormone (ADH) Revenue by Type (2021-2032)
  3. 10.2.1 China Antidiuretic Hormone (ADH) Revenue by Type (2021-2026)
  4. 10.2.2 China Antidiuretic Hormone (ADH) Revenue by Type (2027-2032)
  5. 10.3 China Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032)
  6. 10.4 China Antidiuretic Hormone (ADH) Revenue by Application (2021-2032)
  7. 10.4.1 China Antidiuretic Hormone (ADH) Revenue by Application (2021-2026)
  8. 10.4.2 China Antidiuretic Hormone (ADH) Revenue by Application (2027-2032)
  9. 10.5 China Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antidiuretic Hormone (ADH) Revenue (2021-2032)
  2. 11.2 Asia Antidiuretic Hormone (ADH) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antidiuretic Hormone (ADH) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antidiuretic Hormone (ADH) Revenue by Type (2027-2032)
  5. 11.3 Asia Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antidiuretic Hormone (ADH) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antidiuretic Hormone (ADH) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antidiuretic Hormone (ADH) Revenue by Application (2027-2032)
  9. 11.5 Asia Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antidiuretic Hormone (ADH) Revenue by Country
  11. 11.6.1 Asia Antidiuretic Hormone (ADH) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antidiuretic Hormone (ADH) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antidiuretic Hormone (ADH) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antidiuretic Hormone (ADH) Revenue (2021-2032)
  2. 12.2 SAMEA Antidiuretic Hormone (ADH) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antidiuretic Hormone (ADH) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antidiuretic Hormone (ADH) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antidiuretic Hormone (ADH) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antidiuretic Hormone (ADH) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antidiuretic Hormone (ADH) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antidiuretic Hormone (ADH) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antidiuretic Hormone (ADH) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antidiuretic Hormone (ADH) Revenue by Country
  11. 12.6.1 SAMEA Antidiuretic Hormone (ADH) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antidiuretic Hormone (ADH) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antidiuretic Hormone (ADH) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst